scispace - formally typeset
Open AccessJournal ArticleDOI

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Reads0
Chats0
TLDR
This AASLD 2018 Hepatitis B Guidance provides a data-supported approach to screening, prevention, diagnosis, and clinical management of patients with hepatitis B.
About
This article is published in Hepatology.The article was published on 2018-04-01 and is currently open access. It has received 2399 citations till now. The article focuses on the topics: Hepatitis B & Mass screening.

read more

Citations
More filters
Journal ArticleDOI

Pathogenesis of and New Therapies for Hepatitis D

TL;DR: In this paper, the authors review therapeutic agents in development, designed to disrupt the hepatitis delta virus (HDV) life cycle, that might benefit patients with this devastating disease, which is the only chronic human hepatitis virus infection without a therapy approved by the US Food and Drug Administration.
Journal Article

Cirrhosis: Diagnosis and Management.

TL;DR: Screening tests to assess fibrosis include the aspartate transaminase to platelet ratio index score, Fibrosis 4 score, fibroTest/FibroSure, nonalcoholic fatty liver fibrosis score, standard ultrasonography, and transient elastography, which are most useful in identifying patients with no to minimal fibrosis or advanced fibrosis.
Journal ArticleDOI

Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers

TL;DR: In this comprehensive review, the recent literature discussing serum markers and elastography-based techniques will be covered and the role of non-invasive markers in predicting progression or regression of fibrosis, development of liver-related events and survival needs to be further explored.
Journal ArticleDOI

Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey

TL;DR: Current awareness of chronic viral hepatitis in the United States remains suboptimal and active public health policy to identify persons at risk and provide appropriate management is warranted.
References
More filters
Journal ArticleDOI

Management of hepatocellular carcinoma.

TL;DR: The prevention of Cirrhosis can prevent the development of HCC and progression from chronic HCV infection to advanced fibrosis or cirrhosis may be prevented in 40% of patients who are sustained responders to new antiviral strategies, such as pegylated interferon and ribavirin.
Journal ArticleDOI

AASLD guidelines for the treatment of hepatocellular carcinoma

TL;DR: This paper aims to demonstrate the efforts towards in-situ applicability of EMMARM, as to provide real-time information about concrete mechanical properties such as E-modulus and compressive strength.
Journal ArticleDOI

Chronic hepatitis B: Update 2009

TL;DR: The 2009 update of the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines for Management of Chronic Hepatitis B is now posted online at www.aasld.org, and the recommendation for first-line oral antiviral medications has been changed to tenofovir or entecavir, and adefovir has been moved to second-line Oral antiviral medication.
Journal ArticleDOI

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

TL;DR: More efficacious treatments, mass immunization programs, and safe injection techniques are essential for eliminating HBV infection and reducing global HBV‐related morbidity and mortality.
Related Papers (5)

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Devin Razavi-Shearer, +195 more